-+ 0.00%
-+ 0.00%
-+ 0.00%
HLB Innovation Cuts Verismo Investment to USD 15 Million From USD 28 Million
Share
Listen to the news
HLB Innovation Cuts Verismo Investment to USD 15 Million From USD 28 Million
  • HLB Innovation cut its 2026 investment in Verismo Therapeutics to USD 15 million from USD 28 million in a Nov. 16 correction.
  • The revised acquisition covers 2,830,189 shares, down from 5,283,018, following a contract amendment.
  • Purchases were completed in four installments by Nov. 16, replacing the previously scheduled Dec. 31 completion date.
  • Post-acquisition holdings total 34,187,676 shares, representing a 98.85% stake versus the previously projected 98.93%.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. HLB Innovation Co. Ltd. published the original content used to generate this news brief via DART, the regulatory disclosure system operated by the South Korea Financial Supervisory Service (FSS) (Ref. ID: 20261116900977), on November 16, 2026, and is solely responsible for the information contained therein.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending